Artificial intelligence (AI)-powered immune phenotyping to predict outcomes of immuno-oncology (IO)-based regimens in hepatocellular carcinoma (HCC).
- Resource Type
- Article
- Source
- Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p601-601, 1p
- Subject
- Language
- ISSN
- 0732183X